Loading insider details...
Beta
Latest Form 4 (Aug 8, 2026): Conversion of 782,854 ATTO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 8, 2026 | Attovia Therapeutics, Inc. (ATTO) | Conversion | 782,854 | n/a |
| Jul 25, 2026 | Atara Biotherapeutics, Inc. (ATRA) | Exercise/Conversion | 195,211 | n/a |
| Jun 15, 2026 | FATE THERAPEUTICS INC (FATE) | Grant/Award | 87,900 | n/a |
| Apr 24, 2026 | FATE THERAPEUTICS INC (FATE) | Other (see footnotes) | 266,280 | n/a |
| Apr 3, 2026 | ADC Therapeutics SA (ADCT) | Sale | 196,229 | $736.3K |
| Oct 29, 2025 | ADC Therapeutics SA (ADCT) | Purchase | 3,846,153 | $15.00M |
| Aug 26, 2025 | Shattuck Labs, Inc. (STTK) | Grant/Award | 4,097,730 | n/a |
| Jul 17, 2025 | Shattuck Labs, Inc. (STTK) | Grant/Award | 33,150 | n/a |
| Jun 13, 2025 | ADC Therapeutics SA (ADCT) | Purchase | 15,734,267 | $54.00M |
| May 30, 2025 | FATE THERAPEUTICS INC (FATE) | Grant/Award | 55,000 | n/a |